Work to do in convincing physicians of JAK inhibitors in PsA, says survey
JAK inhibitors for the treatment of autoimmune and inflammatory diseases - ScienceDirect
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases
Current and future status of JAK inhibitors - The Lancet
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
JAK Inhibitor Reistone Biopharma
Treating inflammation with the Janus Kinase inhibitor CP-690,550: Trends in Pharmacological Sciences
Selectivity of Janus Kinase Inhibitors in Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases: Is Expectation the Root of All Headache? | SpringerLink
Janus kinase 3 inhibitor - Wikipedia
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery
JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
JAK inhibitors in the treatment of atopic dermatitis - Journal of Allergy and Clinical Immunology
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
IJMS | Free Full-Text | Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
Ruxolitinib (INCB018424) | ≥99%(HPLC) | Selleck | JAK inhibitor
Janus Kinase Inhibitors Offer New Treatment for Rheumatoid Arthritis, Psoriatic Arthritis, Colitis
JAK inhibitor safety: Distilling the evidence | rheumatology.medicinematters.com
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies | Immunology
JAK inhibitors prevent JAK activation. The signaling cascade that... | Download Scientific Diagram
Selective Janus kinase inhibitors come of age | Nature Reviews Rheumatology
![PDF] Clinical significance of Janus Kinase inhibitor selectivity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fde76c10640b352648c21c3146bef98d22fa5186/2-Figure1-1.png "PDF] Clinical significance of Janus Kinase inhibitor selectivity | Semantic Scholar")
PDF] Clinical significance of Janus Kinase inhibitor selectivity | Semantic Scholar
JAK inhibitors for the treatment of autoimmune and inflammatory diseases - ScienceDirect
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases - Journal of Allergy and Clinical Immunology
